FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20578611000001109: Pramipexole 350microgram tablets (Aspire Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
69238501000001112 Pramipexole 350microgram tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69238601000001111 Pramipexole 350microgram tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Is a Pramipexole 350microgram tablets true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has active ingredient Pramipexole true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate false Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has specific active ingredient Pramipexole dihydrochloride monohydrate true Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) Has basis of strength substance Pramipexole true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Pramipexole 350microgram tablets (Aspire Pharma Ltd) 30 tablet 3 x 10 tablets Has AMP True Pramipexole 350microgram tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier
Pramipexole 350microgram tablets (Aspire Pharma Ltd) 100 tablet 10 x 10 tablets Has AMP True Pramipexole 350microgram tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start